NasdaqGS - Nasdaq Real Time Price USD

Prothena Corporation plc (PRTA)

20.87 +0.31 (+1.51%)
At close: April 26 at 4:00 PM EDT
20.87 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
91,370.00
91,370.00
53,905.00
200,577.00
853.00
Operating Expense
282,406.00
282,406.00
185,462.00
128,602.00
113,587.00
Operating Income
-191,036.00
-191,036.00
-131,557.00
71,975.00
-112,734.00
Net Non Operating Interest Income Expense
31,014.00
31,014.00
6,349.00
42.00
1,369.00
Other Income Expense
-458.00
-458.00
-397.00
-96.00
-62.00
Pretax Income
-160,480.00
-160,480.00
-125,605.00
71,921.00
-111,427.00
Tax Provision
-13,452.00
-13,452.00
-8,656.00
4,946.00
-283.00
Net Income Common Stockholders
-147,028.00
-147,028.00
-116,949.00
66,975.00
-111,144.00
Diluted NI Available to Com Stockholders
-147,028.00
-147,028.00
-116,949.00
66,975.00
-111,144.00
Basic EPS
-2.76
-2.76
-2.47
1.51
-2.78
Diluted EPS
-2.76
-2.76
-2.47
1.38
-2.78
Basic Average Shares
53,216.00
53,216.00
47,369.00
44,228.00
39,915.00
Diluted Average Shares
53,216.00
53,216.00
47,369.00
48,464.00
39,915.00
Total Operating Income as Reported
-191,036.00
-191,036.00
-131,557.00
71,975.00
-112,734.00
Total Expenses
282,406.00
282,406.00
185,462.00
128,602.00
113,587.00
Net Income from Continuing & Discontinued Operation
-147,028.00
-147,028.00
-116,949.00
66,975.00
-111,144.00
Normalized Income
-147,028.00
-147,028.00
-116,949.00
66,975.00
-111,144.00
Interest Income
31,014.00
31,014.00
6,349.00
42.00
1,369.00
Net Interest Income
31,014.00
31,014.00
6,349.00
42.00
1,369.00
EBIT
-191,036.00
-191,036.00
-131,557.00
71,975.00
-112,734.00
EBITDA
-190,108.00
-190,108.00
-130,813.00
73,090.00
-111,220.00
Reconciled Depreciation
928.00
928.00
744.00
1,115.00
1,514.00
Net Income from Continuing Operation Net Minority Interest
-147,028.00
-147,028.00
-116,949.00
66,975.00
-111,144.00
Normalized EBITDA
-190,108.00
-190,108.00
-130,813.00
73,090.00
-111,220.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 12/18/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DNLI Denali Therapeutics Inc.
15.43
+3.14%
 
ACIU AC Immune SA
2.3500
+2.62%
 
FDMT 4D Molecular Therapeutics, Inc.
23.25
-1.19%
 
IMVT Immunovant, Inc.
27.17
-2.09%
 
FOLD Amicus Therapeutics, Inc.
10.28
+1.08%
 
ZNTL Zentalis Pharmaceuticals, Inc.
11.06
+0.68%
 
KURA Kura Oncology, Inc.
19.65
+3.42%
 
BCYC Bicycle Therapeutics plc
22.73
+0.93%
 
CYTK Cytokinetics, Incorporated
65.34
+0.83%
 
AVTE Aerovate Therapeutics, Inc.
21.75
+0.83%